Bridgeway Capital Management’s Oncorus, Inc. ONCR Stock Holding History

Bridgeway Capital Management’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,300	Closed	-$23.2K	–	1479
2023 Q1	$23.2K	Hold	67,300	–	–	﹤0.01%	1351
2022 Q4	$17K	Hold	67,300	–	–	﹤0.01%	1351
2022 Q3	$57K	Sell	67,300 -16,000	-19%	-$20.5K	﹤0.01%	1340
2022 Q2	$105K	Sell	83,300 -35,000	-30%	-$47.5K	﹤0.01%	1215
2022 Q1	$211K	Buy	118,300 +56,300	+91%	+$158K	﹤0.01%	1163
2021 Q4	$327K	Buy	+62,000	New	+$480K	0.01%	1084

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Bridgeway Capital Management's ONCR Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 67,300 shares — an estimated $23.2K sold.

Bridgeway Capital Management first reported a position in ONCR in Q4 2021 and held it in 6 quarters. The position peaked at $327K in Q4 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

Bridgeway Capital Management reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
Bridgeway Capital Management sold 67,300 Oncorus, Inc. shares in Q2 2023, an estimated $23.2K.
Bridgeway Capital Management first reported a position in Oncorus, Inc. in Q4 2021 and held it in 6 quarters.
Bridgeway Capital Management's Oncorus, Inc. position peaked at $327K in Q4 2021.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.